Selskabets formål er investering i kapitalandele og drive dermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 2.8 mio. | -122.1 mio. | 459.8 mio. | 448.3 mio. | 2 | |
CVR: 42396109
Secondary names: Aktieselskabet af 3.5.2021, Impact Co A/S, Systems Clinical Exclusive A/S
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Companies in the same industry and area
CVR 26340470
CVR 26139708
CVR 26792509
CVR 39237342
CVR 40323546